Orffa Animal Nutrition Profile
Key Indicators
- Authorised Capital ₹ 1.65 Cr
as on 28-07-2024
- Paid Up Capital ₹ 1.61 Cr
as on 28-07-2024
- Company Age 15 Year, 8 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 27.37%
(FY 2023)
- Profit 0.96%
(FY 2023)
- Ebitda -0.75%
(FY 2023)
- Net Worth -7.89%
(FY 2023)
- Total Assets -18.58%
(FY 2023)
About Orffa Animal Nutrition
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.65 Cr and a paid-up capital of Rs 1.61 Cr, as per Ministry of Corporate Affairs (MCA) records.
Eddy Ketels, Elizabeth Heemskerk, and Mohit Agarwal serve as directors at the Company.
- CIN/LLPIN
U51109MH2010PTC198781
- Company No.
198781
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Orffa Animal Nutrition Private Limited offer?
Orffa Animal Nutrition Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, Medical Laboratory Instruments, VTM Kit Raw Materials, Fitness Supplements, Gastrointestinal Drugs, Sodium Butyrate, Anti Infective API, L-Selenomethionine, Animal Feed Supplement.
Who are the key members and board of directors at Orffa Animal Nutrition?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Eddy Ketels  | Director | 06-May-2010 | Current |
Elizabeth Heemskerk  | Director | 04-Dec-2020 | Current |
Mohit Agarwal  | Director | 04-Dec-2020 | Current |
Financial Performance of Orffa Animal Nutrition.
Orffa Animal Nutrition Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.37% increase. The company also saw a slight improvement in profitability, with a 0.96% increase in profit. The company's net worth dipped by a decrease of 7.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orffa Animal Nutrition?
In 2023, Orffa Animal Nutrition had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Orffa Animal Nutrition?
Unlock and access historical data on people associated with Orffa Animal Nutrition, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orffa Animal Nutrition, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orffa Animal Nutrition's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
